Area of research
Molecular Biology · Oncology
Research interest
Research interests include Epigenetics and DNA Methylation, Estrogen and related hormone effects, Cancer-related Molecular Pathways, and Ubiquitin and proteasome pathways.
Turning KEAP1 against NRF2.
HbA1c kinetics as a prognostic marker of ophthalmic risk in GLP-1 receptor agonist therapy.
Neural circuits in lung adenocarcinoma modulate immunosurveillance.
β-hydroxybutyrate supplementation boosts the tumor-killing potential of CAR T cells.
Integrating Tumor Biology into Anatomy: The Future of Lung Cancer Staging.
Association of Asthma and Rheumatoid Arthritis: Conundrum Still Unsolved.
Biologically Informed Treatment Approaches Toward Personalized Therapeutic Strategies in Lung Cancer.
Diagnosis of Lung Diseases in the Artificial Intelligence Era.
Pulmonary Arterial Hypertension: Reconfiguring the Vascular Landscape to Reverse Remodeling.
Serum Bilirubin as a Prognostic Factor in Lung Cancer.
Cracking the Code of Immunotherapy Resistance in SCLC: Molecular Insights and Emerging Solutions.
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers.
Update on the relevance of mechanobiological mechanisms in lung cancer.
The potential of tumour mechanotargeting in lung cancer therapeutics.
Aquaporins in Acute Brain Injury: Insights from Clinical and Experimental Studies.
International guidelines on the diagnosis and treatment of NUT carcinoma
CAF-Targeting Antibody-Drug Conjugates (ADCs) in Solid Cancers.
Integrating a genotype-based follow-up algorithm in clinical surveillance to mitigate the risk of pancreatitis in patients treated with GLP-1R agonists.
Targeting the Yin and Yang of KRAS<sup>G12C</sup>.
The IGF Signalling Axis in Lung Cancer: Clinical Significance and Therapeutic Challenges.
Molecular insights into SMARCA2 degradation in SMARCA4-mutant lung cancers.
Comprehensive Liquid Biopsy Approaches for the Clinical Management of Lung Cancer Using Multiple Biological Matrices.
Rezatapopt: A promising small-molecule "refolder" specific for TP53<sup>Y220C</sup> mutant tumors.
FOXM1-AXL/eEF2K Targeting: A Promising Treatment Strategy for Glioblastoma Multiforme Tumors.
The Role of Angiogenetic Factors in Preeclampsia.
The Attractiveness of B7-H3 as a Target for Lung Cancer Treatment.
New Vistas in <i>Mycobacterium tuberculosis</i> Infection and Its Association with Lung Cancer Development.
Non-Small Cell Lung Cancer to Small Cell Lung Cancer Transformation: A Clinical Challenge.
The Prospects of Curcumin in Non-Small Cell Lung Cancer Therapeutics.
Disrupting BMP/TGF-β Signaling: Modulation of AQP1 and TGFB1 in Human Pulmonary Microvascular Endothelial Cells.